O	0	8	Overview
O	9	11	of
O	12	15	the
O	16	26	randomized
O	27	33	trials
O	34	36	of
B-intervention	37	49	radiotherapy
O	50	52	in
B-condition	53	59	ductal
I-condition	60	69	carcinoma
I-condition	70	72	in
I-condition	73	77	situ
O	78	80	of
O	81	84	the
O	85	91	breast
O	91	92	.

O	93	103	Individual
O	104	111	patient
O	112	116	data
O	117	121	were
O	122	131	available
O	132	135	for
O	136	139	all
O	140	144	four
O	145	147	of
O	148	151	the
O	152	162	randomized
O	163	169	trials
O	170	174	that
O	175	180	began
O	181	187	before
O	188	192	1995
O	192	193	,
O	194	197	and
O	198	202	that
O	203	211	compared
O	212	220	adjuvant
O	221	233	radiotherapy
O	234	236	vs
B-control	237	239	no
I-control	240	252	radiotherapy
O	253	262	following
O	263	269	breast
O	269	270	-
O	270	280	conserving
O	281	288	surgery
O	289	292	for
O	293	299	ductal
O	300	309	carcinoma
O	310	312	in
O	313	317	situ
O	318	319	(
O	319	323	DCIS
O	323	324	)
O	324	325	.

O	326	327	A
O	328	333	total
O	334	336	of
B-total-participants	337	341	3729
O	342	347	women
O	348	352	were
O	353	361	eligible
O	362	365	for
O	366	374	analysis
O	374	375	.

O	376	388	Radiotherapy
O	389	396	reduced
O	397	400	the
O	401	409	absolute
B-outcome	410	412	10
I-outcome	412	413	-
I-outcome	413	417	year
I-outcome	418	422	risk
I-outcome	423	425	of
I-outcome	426	429	any
I-outcome	430	441	ipsilateral
I-outcome	442	448	breast
I-outcome	449	454	event
O	455	456	(
O	456	458	ie
O	458	459	,
O	460	466	either
O	467	476	recurrent
O	477	481	DCIS
O	482	484	or
O	485	493	invasive
O	494	500	cancer
O	500	501	)
O	502	504	by
O	505	507	15
O	507	508	.
O	508	509	2
O	509	510	%
O	511	512	(
O	512	514	SE
O	515	516	1
O	516	517	.
O	517	518	6
O	518	519	%
O	519	520	,
B-iv-bin-percent	521	523	12
I-iv-bin-percent	523	524	.
I-iv-bin-percent	524	525	9
I-iv-bin-percent	525	526	%
O	527	529	vs
B-cv-bin-percent	530	532	28
I-cv-bin-percent	532	533	.
I-cv-bin-percent	533	534	1
I-cv-bin-percent	534	535	%
O	536	537	2
O	538	539	P
O	540	541	<
O	541	542	.
O	542	547	00001
O	547	548	)
O	548	549	,
O	550	553	and
O	554	556	it
O	557	560	was
O	561	570	effective
O	571	581	regardless
O	582	584	of
O	585	588	the
O	589	592	age
O	593	595	at
O	596	605	diagnosis
O	605	606	,
O	607	613	extent
O	614	616	of
O	617	623	breast
O	623	624	-
O	624	634	conserving
O	635	642	surgery
O	642	643	,
O	644	647	use
O	648	650	of
O	651	660	tamoxifen
O	660	661	,
O	662	668	method
O	669	671	of
O	672	676	DCIS
O	677	686	detection
O	686	687	,
O	688	694	margin
O	695	701	status
O	701	702	,
O	703	711	focality
O	711	712	,
O	713	718	grade
O	718	719	,
O	720	734	comedonecrosis
O	734	735	,
O	736	748	architecture
O	748	749	,
O	750	752	or
O	753	758	tumor
O	759	763	size
O	763	764	.

O	765	768	The
O	769	781	proportional
O	782	791	reduction
O	792	794	in
B-outcome	795	806	ipsilateral
I-outcome	807	813	breast
I-outcome	814	820	events
O	821	824	was
O	825	832	greater
O	833	835	in
O	836	841	older
O	842	846	than
O	847	849	in
O	850	857	younger
O	858	863	women
O	864	865	(
O	865	867	2P
O	868	869	<
O	870	871	.
O	871	875	0004
O	876	879	for
O	880	890	difference
O	891	898	between
O	899	911	proportional
O	912	922	reductions
O	922	923	;
O	924	926	10
O	926	927	-
O	927	931	year
O	932	940	absolute
O	941	946	risks
O	946	947	:
B-iv-bin-percent	948	950	18
I-iv-bin-percent	950	951	.
I-iv-bin-percent	951	952	5
I-iv-bin-percent	952	953	%
O	954	956	vs
B-cv-bin-percent	957	959	29
I-cv-bin-percent	959	960	.
I-cv-bin-percent	960	961	1
I-cv-bin-percent	961	962	%
O	963	965	at
O	966	970	ages
O	971	972	<
O	972	974	50
O	975	980	years
O	980	981	,
O	982	984	10
O	984	985	.
O	985	986	8
O	986	987	%
O	988	990	vs
O	991	993	27
O	993	994	.
O	994	995	8
O	995	996	%
O	997	999	at
O	1000	1004	ages
O	1005	1006	â‰¥
O	1007	1009	50
O	1010	1015	years
O	1015	1016	)
O	1017	1020	but
O	1021	1024	did
O	1025	1028	not
O	1029	1035	differ
O	1036	1049	significantly
O	1050	1059	according
O	1060	1062	to
O	1063	1066	any
O	1067	1072	other
O	1073	1082	available
O	1083	1089	factor
O	1089	1090	.

O	1091	1095	Even
O	1096	1099	for
O	1100	1105	women
O	1106	1110	with
O	1111	1119	negative
O	1120	1127	margins
O	1128	1131	and
O	1132	1137	small
O	1138	1141	low
O	1141	1142	-
O	1142	1147	grade
O	1148	1154	tumors
O	1154	1155	,
O	1156	1159	the
O	1160	1168	absolute
O	1169	1178	reduction
O	1179	1181	in
O	1182	1185	the
B-outcome	1186	1188	10
I-outcome	1188	1189	-
I-outcome	1189	1193	year
I-outcome	1194	1198	risk
I-outcome	1199	1201	of
I-outcome	1202	1213	ipsilateral
I-outcome	1214	1220	breast
I-outcome	1221	1227	events
O	1228	1231	was
O	1232	1234	18
O	1234	1235	.
O	1235	1236	0
O	1236	1237	%
O	1238	1239	(
O	1239	1241	SE
O	1242	1243	5
O	1243	1244	.
O	1244	1245	5
O	1245	1246	,
B-iv-bin-percent	1247	1249	12
I-iv-bin-percent	1249	1250	.
I-iv-bin-percent	1250	1251	1
I-iv-bin-percent	1251	1252	%
O	1253	1255	vs
B-cv-bin-percent	1256	1258	30
I-cv-bin-percent	1258	1259	.
I-cv-bin-percent	1259	1260	1
I-cv-bin-percent	1260	1261	%
O	1261	1262	,
O	1263	1265	2P
O	1266	1267	=
O	1268	1269	.
O	1269	1272	002
O	1272	1273	)
O	1273	1274	.

O	1275	1280	After
O	1281	1283	10
O	1284	1289	years
O	1290	1292	of
O	1293	1299	follow
O	1299	1300	-
O	1300	1302	up
O	1302	1303	,
O	1304	1309	there
O	1310	1313	was
O	1313	1314	,
O	1315	1322	however
O	1322	1323	,
O	1324	1326	no
O	1327	1338	significant
O	1339	1345	effect
O	1346	1348	on
O	1349	1355	breast
O	1356	1362	cancer
O	1363	1372	mortality
O	1372	1373	,
O	1374	1383	mortality
O	1384	1388	from
O	1389	1395	causes
O	1396	1401	other
O	1402	1406	than
O	1407	1413	breast
O	1414	1420	cancer
O	1420	1421	,
O	1422	1424	or
O	1425	1428	all
O	1428	1429	-
O	1429	1434	cause
O	1435	1444	mortality
O	1444	1445	.
